Literature DB >> 25581830

Immune-mediated reactions to anti-tumor necrosis factors in inflammatory bowel disease.

Joseph D Feuerstein1, Garret Cullen, Adam S Cheifetz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25581830     DOI： 10.1097/MIB.0000000000000279

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

Review 1.  Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.

Authors:  Pieter Hindryckx; Gregor Novak; Niels Vande Casteele; Reena Khanna; Debby Laukens; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration.

Authors:  Helena Edlund; Casper Steenholdt; Mark A Ainsworth; Eva Goebgen; Jørn Brynskov; Ole Ø Thomsen; Wilhelm Huisinga; Charlotte Kloft
Journal:  AAPS J       Date:  2016-10-13       Impact factor: 4.009

Review 3.  New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.

Authors:  Kartikeya Tripathi; Joseph D Feuerstein
Journal:  Drugs Context       Date:  2019-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.